Where does Nura BIO, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nura BIO, Inc. ranks #49,228 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nura BIO, Inc. hold?

Nura BIO, Inc. holds 5 US utility patents granted between 2023 and 2025, spanning 4 technology areas.

What is Nura BIO, Inc.'s Innovation Score?

Nura BIO, Inc. has an Innovation Score of 48.3 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nura BIO, Inc. focus on?

Nura BIO, Inc.'s top technology area is C07D (Heterocyclic Compounds) with 5 patents. Grants appear in 4 CPC subclasses total.

Is Nura BIO, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Nura BIO, Inc..

What does claim depth mean for Nura BIO, Inc.'s patents?

Nura BIO, Inc.'s patents average 29.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nura BIO, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nura BIO, Inc.

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nura ranks #49,228 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.

#49,228
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.3/100): 29.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49228 · US Corporation #49,228 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,228/49,997
PHOTO-FINISH Nuformix
CPC-NARROW C07D · 4 areas
INNOV-PAR 48.3/100
CLAIMS-DENSE 29.6 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Nuformix Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Nura BIO · this assignee

48
3D Lighting… · lowest

7

What this shows Nura's Innovation Score is 48.3/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Nura's grants concentrate

Nura BIO, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2023. By volume, Nura sits between Nuformix Limited and NUU Garden Corporation.

Nura's three-year grant acceleration

Nura BIO, Inc. shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nuformix

5
Nuformix

5
Numnum

5
Nuova Ompi S R L…

5
Nusil Technology

5
Nutjobs

5
Nutrien Solutions

5
NUU Garden

5
Nura BIO ◀

5

What this shows Nura holds 5 patents at rank #49,092, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nura

By rank, the assignees closest to #49,092 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Nura's primary technology class.

Nura's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Nura BIO, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	1	20.0%
2024	3	60.0%
2025partial year	1	20.0%

Which technologies does Nura BIO, Inc. patent most?

C07D - Heterocyclic Compounds 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#49,228

of 49,997 tracked assignees

Innovation Score

48.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Nura BIO, Inc.'s patent record in context - here's where to go next.

Nura BIO, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #49,228 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nura BIO, Inc. against Nuformix Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.